KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $7.6 billion.

  • Johnson & Johnson's Accumulated Expenses fell 3361.57% to $7.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 billion, marking a year-over-year decrease of 3361.57%. This contributed to the annual value of $8.5 billion for FY2024, which is 1628.48% down from last year.
  • According to the latest figures from Q3 2025, Johnson & Johnson's Accumulated Expenses is $7.6 billion, which was down 3361.57% from $7.4 billion recorded in Q2 2025.
  • Johnson & Johnson's Accumulated Expenses' 5-year high stood at $14.0 billion during Q1 2021, with a 5-year trough of $7.4 billion in Q2 2025.
  • Its 5-year average for Accumulated Expenses is $11.0 billion, with a median of $10.7 billion in 2023.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first soared by 4377.77% in 2021, then tumbled by 3361.57% in 2025.
  • Over the past 5 years, Johnson & Johnson's Accumulated Expenses (Quarter) stood at $13.8 billion in 2021, then fell by 13.46% to $12.0 billion in 2022, then decreased by 14.57% to $10.2 billion in 2023, then decreased by 16.28% to $8.5 billion in 2024, then fell by 11.09% to $7.6 billion in 2025.
  • Its Accumulated Expenses was $7.6 billion in Q3 2025, compared to $7.4 billion in Q2 2025 and $7.9 billion in Q1 2025.